All reagents were pre-dissolved in DMSO to form stock solutions. Concentrations of the free peptide was determined by UV at 280 nm either in 50 mM pH 7 phosphate buffer or 1 % aq.
ammonia. 5 Reaction was generally completed within 2 -4 h as determined by analytical HPLC.
The desired products were subsequently isolated by semi-preparative HPLC using a gradient elution of 10 -30 % solvent B for the first 25 min followed by 30 % B for another 17 min.
Purity of the conjugates was assessed on an analytical column assessed using a gradient elution of 8 -30 % B for the first 10 min, 30 % B for another 8 min and finally 30 -80 % B for 7 min.
S-4
Oxaliplatin(IV)-AHNP conjugate (4a). Synthesis of 4a was similar to 3a but using 2 as the platinum(IV) scaffold instead. ; Purity (HPLC): 96 % at 280 nm.
Cell culture. The HER2/neu over-expressing human gastric cancer cell-line NCI-N87 and breast cancer cell-line BT474 were obtained from ATCC. The A2780 human ovarian cancer cell line was obtained from EACC. All cell-lines were cultured in complete RPMI 1640 medium containing 10 % fetal bovine serum (FBS) and maintained in a humidified of 5 % CO2
at 37  C. 
Annexin-V apoptosis assay (24 h
)
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Characterisation of compounds **Cyclohexane ring 
